Curaleaf Holdings (CURLF) Operating Margin Growth (5y) (2024 - 2026)

Curaleaf Holdings (CURLF) Operating Margin Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-
10	Curaleaf Holdings	2.48 Bn	2.38 Bn	169.91 Mn

Download Data